Logo image of ZPTA

ZAPATA COMPUTING HOLDINGS IN (ZPTA) Stock Fundamental Analysis

NASDAQ:ZPTA - Nasdaq - US98906V1008 - Common Stock - Currency: USD

0.079  -0.01 (-12.9%)

After market: 0.0764 0 (-3.29%)

Fundamental Rating

1

Taking everything into account, ZPTA scores 1 out of 10 in our fundamental rating. ZPTA was compared to 281 industry peers in the Software industry. Both the profitability and financial health of ZPTA have multiple concerns. ZPTA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ZPTA had negative earnings in the past year.
ZPTA had a negative operating cash flow in the past year.
ZPTA Yearly Net Income VS EBIT VS OCF VS FCFZPTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -10M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -370.12%, ZPTA is doing worse than 98.94% of the companies in the same industry.
Industry RankSector Rank
ROA -370.12%
ROE N/A
ROIC N/A
ROA(3y)-123.16%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZPTA Yearly ROA, ROE, ROICZPTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 500 1K

1.3 Margins

The Gross Margin of ZPTA (43.23%) is worse than 73.76% of its industry peers.
ZPTA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZPTA Yearly Profit, Operating, Gross MarginsZPTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -100 -200 -300 -400 -500

More info and screens

0

2. Health

2.1 Basic Checks

ZPTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZPTA has been increased compared to 1 year ago.
Compared to 1 year ago, ZPTA has a worse debt to assets ratio.
ZPTA Yearly Shares OutstandingZPTA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
ZPTA Yearly Total Debt VS Total AssetsZPTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

ZPTA has an Altman-Z score of -21.60. This is a bad value and indicates that ZPTA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ZPTA (-21.60) is worse than 94.68% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -21.6
ROIC/WACCN/A
WACC8.94%
ZPTA Yearly LT Debt VS Equity VS FCFZPTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.41 indicates that ZPTA may have some problems paying its short term obligations.
The Current ratio of ZPTA (0.41) is worse than 94.68% of its industry peers.
A Quick Ratio of 0.41 indicates that ZPTA may have some problems paying its short term obligations.
ZPTA has a Quick ratio of 0.41. This is amonst the worse of the industry: ZPTA underperforms 94.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.41
ZPTA Yearly Current Assets VS Current LiabilitesZPTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

ZPTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1697.58%.
EPS 1Y (TTM)-1697.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7763.9%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 13.99% on average over the next years. This is quite good.
The Revenue is expected to grow by 62.71% on average over the next years. This is a very strong growth
EPS Next Y-43.71%
EPS Next 2Y18.79%
EPS Next 3Y13.99%
EPS Next 5YN/A
Revenue Next Year25.64%
Revenue Next 2Y58.52%
Revenue Next 3Y62.71%
Revenue Next 5YN/A

3.3 Evolution

ZPTA Yearly Revenue VS EstimatesZPTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M 15M 20M
ZPTA Yearly EPS VS EstimatesZPTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.5 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ZPTA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ZPTA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZPTA Price Earnings VS Forward Price EarningsZPTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZPTA Per share dataZPTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

ZPTA's earnings are expected to grow with 13.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.79%
EPS Next 3Y13.99%

More info and screens

0

5. Dividend

5.1 Amount

ZPTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZAPATA COMPUTING HOLDINGS IN

NASDAQ:ZPTA (10/25/2024, 8:15:56 PM)

After market: 0.0764 0 (-3.29%)

0.079

-0.01 (-12.9%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-18 2024-03-18
Earnings (Next)N/A N/A
Inst Owners6.86%
Inst Owner Change0%
Ins Owners14.44%
Ins Owner Change91.74%
Market Cap3.20M
Analysts82.86
Price Target1.79 (2165.82%)
Short Float %0.68%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.69%
PT rev (3m)16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.28
EYN/A
EPS(NY)-0.6
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0.06
BVpS-0.52
TBVpS-0.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -370.12%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.23%
FCFM N/A
ROA(3y)-123.16%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.41
Altman-Z -21.6
F-Score2
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)80.44%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1697.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7763.9%
EPS Next Y-43.71%
EPS Next 2Y18.79%
EPS Next 3Y13.99%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year25.64%
Revenue Next 2Y58.52%
Revenue Next 3Y62.71%
Revenue Next 5YN/A
EBIT growth 1Y-275.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.49%
EBIT Next 3Y8.18%
EBIT Next 5YN/A
FCF growth 1Y-664.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-664.92%
OCF growth 3YN/A
OCF growth 5YN/A